Reduced Environmental Stimulation in Anorexia Nervosa: An Early-Phase Clinical Trial

Sahib S Khalsa, Scott E Moseman, Hung-Wen Yeh, Valerie Upshaw, Beth Persac, Eric Breese, Rachel C Lapidus, Sheridan Chappelle, Martin P Paulus, Justin S Feinstein, Sahib S Khalsa, Scott E Moseman, Hung-Wen Yeh, Valerie Upshaw, Beth Persac, Eric Breese, Rachel C Lapidus, Sheridan Chappelle, Martin P Paulus, Justin S Feinstein

Abstract

Reduced Environmental Stimulation Therapy (REST) alters the balance of sensory input to the nervous system by systematically attenuating sensory signals from visual, auditory, thermal, tactile, vestibular, and proprioceptive channels. Previous research from our group has shown that REST via floatation acutely reduces anxiety and blood pressure (BP) while simultaneously heightening interoceptive awareness in clinically anxious populations. Anorexia nervosa (AN) is an eating disorder characterized by elevated anxiety, distorted body representation, and abnormal interoception, raising the question of whether REST might positively impact these symptoms. However, this approach has never been studied in eating disorders, and it is unknown whether exposure to floatation REST might worsen AN symptoms. To examine these possibilities, we conducted an open-label study to investigate the safety and tolerability of REST in AN. We also explored the acute impact of REST on BP, affective symptoms, body image disturbance, and interoception. Twenty-one partially weight-restored AN outpatients completed a protocol involving four sequential sessions of REST: reclining in a zero-gravity chair, floating in an open pool, and two sessions of floating in an enclosed pool. All sessions were 90 min, approximately 1 week apart. We measured orthostatic BP before and immediately after each session (primary outcome), in addition to collecting BP readings every 10 min during the session using a wireless waterproof system as a secondary outcome measure. Each participant's affective state, awareness of interoceptive sensations, and body image were assessed before and after every session (exploratory outcomes). There was no evidence of orthostatic hypotension following floating, and no adverse events (primary outcome). Secondary analyses revealed that REST induced statistically significant reductions in BP (p < 0.001; Cohen's d, 0.2-0.5), anxiety (p < 0.001; Cohen's d, >1) and negative affect (p < 0.01; Cohen's d, >0.5), heightened awareness of cardiorespiratory (p < 0.01; Cohen's d, 0.2-0.5) but not gastrointestinal sensations, and reduced body image dissatisfaction (p < 0.001; Cohen's d, >0.5). The findings from this initial trial suggest that individuals with AN can safely tolerate the physical effects of REST via floatation. Future randomized controlled trials will need to investigate whether these initial observations of improved anxiety, interoception, and body image disturbance occur in acutely ill AN populations.

Clinical trial registration: ClinicalTrials.gov; Identifier: NCT02801084 (April 01, 2016).

Keywords: body awareness; body image; eating disorder; floatation therapy; interoception; interoceptive awareness; stress.

Copyright © 2020 Khalsa, Moseman, Yeh, Upshaw, Persac, Breese, Lapidus, Chappelle, Paulus and Feinstein.

Figures

FIGURE 1
FIGURE 1
REST at LIBR. (Left) Chair-REST. (Middle) Floatation-REST in an open pool. (Right) Floatation-REST in an enclosed pool. The open (middle) and enclosed (right) pools are both 2.44 m in diameter and 0.28 m in depth. The domed pool contains an enclosure with a 2.44-m domed ceiling. Each pool contains 11 in. of reverse osmosis water saturated with ∼816 kg of USP grade Epsom salt (magnesium sulfate), creating a dense saltwater solution that is maintained at a specific gravity of ∼1.26, allowing participants to effortlessly float on their back while the water hovers just above the ears. The temperature of the water and the temperature of the air are both calibrated to match the temperature of the skin (∼35.0°C). For more details about how our float pools were engineered to minimize exteroceptive sensory stimulation to the nervous system, please see Feinstein et al. (2018a; 2018b).
FIGURE 2
FIGURE 2
Approximate timeline of assessments during each REST session. Sensor application included the application of a wireless blood pressure monitor and waterproof cast. The total duration of each session was approximately 3.5 h.
FIGURE 3
FIGURE 3
Consort flow diagram. This figure illustrates the number of participants included in enrollment, the number allocated to the REST intervention, the number withdrawn, and the number included in the data analysis.
FIGURE 4
FIGURE 4
Individual orthostatic blood pressure changes. (A) The figure displays each individual’s change in systolic blood pressure (BP) from lying to standing at the end of each REST session. There was no evidence of systolic orthostatic hypotension in any individual, i.e., a reduction in systolic BP below 20 mmHg (red dashed line). (B) The figure displays each individual’s change in diastolic BP from lying to standing at the end of each REST session. There was no evidence of diastolic orthostatic hypotension in any individual, i.e., a reduction in systolic BP below 10 mmHg (red dashed line). Note that BP was not measured during the second pool session and is therefore unlisted.
FIGURE 5
FIGURE 5
Group summary of orthostatic blood pressure measures. Each figure displays the mean and standard error for the lying, sitting, and standing blood pressure measurements, at pre- and postsession intervals for the (A) chair-REST (B) the first and (C) final floatation-REST sessions.
FIGURE 6
FIGURE 6
Blood pressure responses during REST. (A) Systolic BP. (B) Diastolic BP. Significant reductions in both systolic and diastolic BP occurred between the 25th and 65th minutes of REST.
FIGURE 7
FIGURE 7
Effect size estimates for the secondary outcome measures. Note that there were no blood pressure measures taken during the second pool float, and therefore that field is blank. A table showing the exact effect size estimates and associated confidence intervals is located in the Supplementary Material.

References

    1. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association.
    1. Arcelus J., Mitchell A. J., Wales J., Nielsen S. (2011). Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch. Gen. Psychiatry 68 724–731. 10.1001/archgenpsychiatry.2011.74
    1. Barabasz M. (1993). “REST: a key facilitator in the treatment of eating disorders,” in Clinical and Experimental Restricted Environmental Stimulation: New Developments and Perspectives, eds Barabasz A. F., Barabasz M. (New York, NY: Springer-Verlag; ), 121–126. 10.1007/978-1-4684-8583-7_15
    1. Bates D., Maechler M., Boker B., Walker S. (2015). Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67 1–48.
    1. Berends T., Boonstra N., van Elburg A. (2018). Relapse in anorexia nervosa: a systematic review and meta-analysis. Curr. Opin. Psychiatry 31 445–455. 10.1097/yco.0000000000000453
    1. Berner L. A., Simmons A. N., Wierenga C. E., Bischoff-Grethe A., Paulus M. P., Bailer U. F., et al. (2017). Altered interoceptive activation before, during, and after aversive breathing load in women remitted from anorexia nervosa. Psychol. Med. 48 142–154. 10.1017/s0033291717001635
    1. Bulik C. M., Berkman N. D., Brownley K. A., Sedway J. A., Lohr K. N. (2007). Anorexia nervosa treatment: a systematic review of randomized controlled trials. Int. J. Eat. Disord. 40 310–320.
    1. Bulik C. M., Sullivan P. F., Fear J. L., Joyce P. R. (1997). Eating disorders and antecedent anxiety disorders: a controlled study. Acta Psychiatr. Scand. 96 101–107. 10.1111/j.1600-0447.1997.tb09913.x
    1. Cash T. F., Fleming E. C., Alindogan J., Steadman L., Whitehead A. (2002). Beyond body image as a trait: the development and validation of the body image states scale. Eat. Disord. 10 103–113. 10.1080/10640260290081678
    1. Cohen P., Cohen J., Aiken L. S., West S. G. (1999). The problem of units and the circumstance for POMP. Mult. Behav. Res. 34 315–346. 10.1207/s15327906mbr3403_2
    1. Couturier J., Kimber M., Szatmari P. (2013). Efficacy of family-based treatment for adolescents with eating disorders: a systematic review and meta-analysis. Int. J. Eat. Disord. 46 3–11. 10.1002/eat.22042
    1. Czajkowski S. M., Powell L. H., Adler N., Naar-King S., Reynolds K. D., Hunter C. M., et al. (2015). From ideas to efficacy: the ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol. 34 971–82. 10.1037/hea0000161
    1. Fairburn C. G., Beglin S. J. (2008). Eating Disorder Examination Questionnaire (6.0). New York, NY: Guilford Press.
    1. Feinstein J. S., Khalsa S. S., Yeh H., Al Zoubi O., Arevian A. C., Wohlrab C., et al. (2018a). The elicitation of relaxation and interoceptive awareness using floatation therapy in individuals with high anxiety sensitivity. Biol. Psychiatry 3 555–562. 10.1016/j.bpsc.2018.02.005
    1. Feinstein J. S., Khalsa S. S., Yeh H. W., Wohlrab C., Simmons W. K., Stein M. B., et al. (2018b). Examining the short-term anxiolytic and antidepressant effect of Floatation-REST. PLoS One 13:e0190292. 10.1371/journal.pone.0190292
    1. Freedland K. E., Mohr D. C., Davidson K. W., Schwartz J. E. (2011). Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom. Med. 73 323–335. 10.1097/psy.0b013e318218e1fb
    1. Friederich H. C., Herzog W. (2011). Cognitive-behavioral flexibility in anorexia nervosa. Curr. Top. Behav. Neurosci. 6 111–123. 10.1007/7854_2010_83
    1. Galsworthy-Francis L., Allan S. (2014). Cognitive behavioural therapy for anorexia nervosa: a systematic review. Clin. Psychol. Rev. 34 54–72. 10.1016/j.cpr.2013.11.001
    1. Halmi K. A., Sunday S. R. (1991). Temporal patterns of hunger and fullness ratings and related cognitions in anorexia and bulimia. Appetite 16 219–237. 10.1016/0195-6663(91)90060-6
    1. Himmerich H., Treasure J. (2018). Psychopharmacological advances in eating disorders. Expert Rev. Clin. Pharmacol. 11 95–108.
    1. Hoang U., Goldacre M., James A. (2014). Mortality following hospital discharge with a diagnosis of eating disorder: national record linkage study. England, 2001-2009. Int. J. Eat. Disord. 47 507–515. 10.1002/eat.22249
    1. Jonsson K., Kjellgren A. (2016). Promising effects of treatment with flotation-REST (restricted environmental stimulation technique) as an intervention for generalized anxiety disorder (GAD): a randomized controlled pilot trial. BMC Complement Altern. Med. 16:108. 10.1186/s12906-016-1089-x
    1. Kaufmann H. (1996). Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin. Auton. Res. 6 125–126. 10.1007/bf02291236
    1. Kaye W. H., Bulik C. M., Thornton L., Barbarich N., Masters K. (2004). Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am. J. Psychiatry 161 2215–2221.
    1. Kaye W. H., Fudge J. L., Paulus M. (2009). New insights into symptoms and neurocircuit function of anorexia nervosa. Nat. Rev. Neurosci. 10 573–584. 10.1038/nrn2682
    1. Kaye W. H., Wagner A., Fudge J. L., Paulus M. (2011). “Neurocircuity of eating disorders,” in Behavioral Neurobiology of Eating Disorders Current Topics in Behavioral Neurosciences, Geyer M., Jolla L., Ellenbroek B., Marsden C. (New York, NY: Springer-Verlag Publishing; ), 37–57. 10.1007/7854_2010_85
    1. Keel P. K., Dorer D. J., Franko D. L., Jackson S. C., Herzog D. B. (2005). Postremission predictors of relapse in women with eating disorders. Am. J. Psychiatry 162 2263–2268. 10.1176/appi.ajp.162.12.2263
    1. Kerr K. L., Moseman S. E., Avery J. A., Bodurka J., Zucker N. L., Simmons W. K. (2016). Altered insula activity during visceral interoception in weight-restored patients with anorexia nervosa. Neuropsychopharmacology 41 521–528. 10.1038/npp.2015.174
    1. Keshaviah A., Edkins K., Hastings E. R., Krishna M., Franko D. L., Herzog D. B., et al. (2014). Re-examining premature mortality in anorexia nervosa: a meta-analysis redux. Compr. Psychiatry 55 1773–1784. 10.1016/j.comppsych.2014.07.017
    1. Khalsa S. S., Craske M. G., Li W., Vangala S., Strober M., Feusner J. D. (2015). Altered interoceptive awareness in anorexia nervosa: effects of meal anticipation, consumption and bodily arousal. Int. J. Eat. Disord. 48 889–897. 10.1002/eat.22387
    1. Khalsa S. S., Portnoff L. C., McCurdy-McKinnon D., Feusner J. D. (2017). What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. J. Eat. Disord. 5:20.
    1. Klump K. L., Wonderlich S., Lehoux P., Lilenfeld L. R., Bulik C. M. (2002). Does environment matter? A review of nonshared environment and eating disorders. Int. J. Eat. Disord. 31 118–135. 10.1002/eat.10024
    1. Kuznetsova A., Brockhoff P. B., Christensen R. H. B. (2017). lmerTest package: Tests in linear mixed effects models. J. Stat. Softw. 82 1–26.
    1. Lanier J. B., Mote M. B., Clay E. C. (2011). Evaluation and management of orthostatic hypotension. Am. Fam. Physician 84 527–536.
    1. Lenth R. (2019). Estimated Marginal Mean, Aka Least-Squares Means. R Package veRsion 1.3.5.
    1. Levine M. P., Smolak L. (2010). “Cultural influences on body image and the eating disorders,” in The Oxford Handbook of Eating Disorders, ed. Agras W. S. (Oxford: Oxford University Press; ).
    1. Lilenfeld L. R., Wonderlich S., Riso L. P., Crosby R., Mitchell J. (2006). Eating disorders and personality: a methodological and empirical review. Clin. Psychol. Rev. 26 299–320. 10.1016/j.cpr.2005.10.003
    1. Lock J. (2010). Treatment of adolescent eating disorders: progress and challenges. Min. Psichiatr. 51 207–216.
    1. Luce K. H., Crowther J. H., Pole M. (2008). Eating Disorder Examination Questionnaire (EDE-Q): norms for undergraduate women. Int. J. Eat. Disord. 41 273–276. 10.1002/eat.20504
    1. Martin E., Dourish C. T., Rotshtein P., Spetter M. S., Higgs S. (2019). Interoception and disordered eating: a systematic review. Neurosci. Biobehav. Rev. 107 166–191. 10.1016/j.neubiorev.2019.08.020
    1. McElroy S. L., Guerdjikova A. I., Mori N., Keck P. E., Jr. (2015). Psychopharmacologic treatment of eating disorders: emerging findings. Curr. Psychiatry Rep. 17:35.
    1. Meier S. M., Bulik C. M., Thornton L. M., Mattheisen M., Mortensen P. B., Petersen L. (2015). Diagnosed anxiety disorders and the risk of subsequent anorexia nervosa: a Danish population register study. Eur. Eat. Disord. Rev. 23 524–530. 10.1002/erv.2402
    1. O’Brien E., Atkins N., Stergiou G., Karpettas N., Parati G., Asmar R., et al. (2010). European society of hypertension international protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press. Monit. 15 23–38. 10.1097/mbp.0b013e3283360e98
    1. Pike K. M. (1998). Long-term course of anorexia nervosa: response, relapse, remission, and recovery. Clin. Psychol. Rev. 18 447–475. 10.1016/s0272-7358(98)00014-2
    1. Pinheiro J., Bates D., DebRoy S., Sarkar D. R Core Team. (2018). nlme: Linear and Nonlinear Mixed Effects Models.
    1. Robinson P. H. (1989). Perceptivity and paraceptivity during measurement of gastric emptying in anorexia and bulimia nervosa. Br. J. Psychiatry 154 400–405. 10.1192/bjp.154.3.400
    1. Sachs K. V., Harnke B., Mehler P. S., Krantz M. J. (2016). Cardiovascular complications of anorexia nervosa: a systematic review. Int. J. Eat. Disord. 49 238–248. 10.1002/eat.22481
    1. Sato Y., Fukudo S. (2015). Gastrointestinal symptoms and disorders in patients with eating disorders. Clin. J. Gastroenterol. 8 255–263. 10.1007/s12328-015-0611-x
    1. Spielberger C. D., Gorssuch R. L., Lushene P. R., Vagg P. R., Jacobs G. A. (1983). Manual for the State-Trait Anxiety Inventory. London: Consulting Psychologists Press, Inc.
    1. Steinglass J. E., Kaplan S. C., Liu Y., Wang Y., Walsh B. T. (2014). The (lack of) effect of alprazolam on eating behavior in anorexia nervosa: a preliminary report. Int. J. Eat. Disord. 47 901–904. 10.1002/eat.22343
    1. Steinhausen H. C. (2002). The outcome of anorexia nervosa in the 20th century. Am. J. Psychiatry 159 1284–1293. 10.1176/appi.ajp.159.8.1284
    1. Suedfeld P., Borrie R. A. (1999). Health and therapeutic applications of chamber and flotation restricted environmental therapy (REST). Psychol. Health 14 545–566. 10.1080/08870449908407346
    1. Sullivan P. F. (1995). Mortality in anorexia nervosa. Am. J. Psychiatry 152 1073–1074. 10.1176/ajp.152.7.1073
    1. Suokas J. T., Suvisaari J. M., Gissler M., Lofman R., Linna M. S., Raevuori A., et al. (2013). Mortality in eating disorders: a follow-up study of adult eating disorder patients treated in tertiary care, 1995-2010. Psychiatry Res. 210 1101–1106. 10.1016/j.psychres.2013.07.042
    1. Swami V., Salem N., Furnham A., Tovee M. J. (2008). Initial examination of the validity and reliability of the female photographic figure rating scale for body image assessment. Personal. Individ. Differ. 44 1752–1761. 10.1016/j.paid.2008.02.002
    1. Swami V., Stieger S., Harris A. S., Nader I. W., Pietschnig J., Voracek M., et al. (2012). Further investigation of the validity and reliability of the photographic figure rating scale for body image assessment. J. Pers. Assess. 94 404–409. 10.1080/00223891.2012.660293
    1. Tchanturia K., Lounes N., Holttum S. (2014). Cognitive remediation in anorexia nervosa and related conditions: a systematic review. Eur. Eat. Disord. Rev. 22 454–462. 10.1002/erv.2326
    1. Todd J., Aspell J. E., Barron D., Swami V. (2019a). An exploration of the associations between facets of interoceptive awareness and body image in adolescents. Body Image 31 171–180. 10.1016/j.bodyim.2019.10.004
    1. Todd J., Aspell J. E., Barron D., Swami V. (2019b). Multiple dimensions of interoceptive awareness are associated with facets of body image in British adults. Body Image 29 6–16. 10.1016/j.bodyim.2019.02.003
    1. Tylka T. L., Wood-Barcalow N. L. (2015). The body appreciation scale-2: item refinement and psychometric evaluation. Body Image 12 53–67. 10.1016/j.bodyim.2014.09.006
    1. Watson D., Clark L. A., Tellegen A. (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 54 1063–1070. 10.1037/0022-3514.54.6.1063
    1. Wolpe J. (1968). Psychotherapy by reciprocal inhibition. Conditional Reflex 3 234–240.
    1. World Health Organization (1993). The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva: WHO.
    1. Zucker N. L., Herzog D., Moskovich A., Merwin R., Lin T. (2011). Incorporating dispositional traits into the treatment of anorexia nervosa. Curr. Top. Behav. Neurosci. 6 289–314. 10.1007/7854_2010_92

Source: PubMed

3
購読する